| abstract |
Use of 17β-[(1-methyl-1,4-dihydro-3-pyridinyl)carbonyloxy]estra-1,3,5(10) trien-3-ol, also known as E2-CDS, in the preparation of a medicament for treating female sexual dysfunction in a female mammal, employing very low doses of the compound which do not elevate average steady-state peripheral estradiol levels to above about 50-60 pg/ml. Also, use of E2-CDS in the preparation of a medicament for treating male sexual function in a male mammal, employing very low doses of the compound which do not substantially elevate average peripheral estradiol levels to above average normal peripheral levels in the male mammal. |